Strides Pharma Science Ltd. - Research Center
532531 STAR Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
1,195.91 |
1,015.61 |
904.43 |
895.22 |
1,083.79 |
Operating profit |
128.79 |
98.83 |
-66.56 |
21.48 |
55.15 |
Interest |
98.53 |
76.70 |
60.68 |
38.15 |
36.09 |
Gross profit |
61.90 |
56.12 |
-99.30 |
75.66 |
50.22 |
EPS (Rs) |
1.93 |
1.03 |
-7.78 |
20.37 |
-0.30 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
31.64 |
33.99 |
27.94 |
92.33 |
31.16 |
Stock adjustment |
17.85 |
7.12 |
0.30 |
42.59 |
71.66 |
Raw material |
568.05 |
504.04 |
578.98 |
475.71 |
459.72 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
199.07 |
162.95 |
137.54 |
121.01 |
151.08 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
282.15 |
242.67 |
254.17 |
234.43 |
346.17 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
43.89 |
42.80 |
48.65 |
50.64 |
53.73 |
Taxation |
0.29 |
4.04 |
-77.70 |
-157.88 |
-0.80 |
Net profit / loss |
17.71 |
9.29 |
-70.25 |
182.90 |
-2.71 |
Extra ordinary item |
-0.01 |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
91.96 |
90.30 |
90.29 |
89.79 |
89.78 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
10.77 |
9.73 |
-7.36 |
2.40 |
5.09 |
GPM (%) |
5.04 |
5.35 |
-10.65 |
7.66 |
4.50 |
NPM (%) |
1.44 |
0.88 |
-7.53 |
18.52 |
-0.24 |